These results suggest that the amelioration of MASLD observed in our study was partly due to reciprocal reactions between phosphorylated AMPKα and activated PPARα via pemafibrate stimulation. The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatotic liver disease.